Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Haindl, MT; Üçal, M; Wonisch, W; Lang, M; Nowakowska, M; Adzemovic, MZ; Khalil, M; Enzinger, C; Hochmeister, S.
Vitamin D-An Effective Antioxidant in an Animal Model of Progressive Multiple Sclerosis.
Nutrients. 2023; 15(15):
Doi: 10.3390/nu15153309
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Haindl Michaela Tanja
- Hochmeister Sonja
- Co-Autor*innen der Med Uni Graz
- Enzinger Christian
- Khalil Michael
- Nowakowska-Desplantes Marta
- Ücal Muammer
- Wonisch Willibald
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Vitamin D (VD) is the most discussed antioxidant supplement for multiple sclerosis (MS) patients and many studies suggest correlations between a low VD serum level and onset and progression of the disease. While many studies in animals as well as clinical studies focused on the role of VD in the relapsing-remitting MS, knowledge is rather sparse for the progressive phase of the disease and the development of cortical pathology. In this study, we used our established rat model of cortical inflammatory demyelination, resembling features seen in late progressive MS, to address the question about whether VD could have positive effects on reducing cortical pathology, oxidative stress, and neurofilament light chain (NfL) serum levels. For this purpose, we used male Dark Agouti (DA) rats, with one group being supplemented with VD (400 IE per week; VD+) from the weaning on at age three weeks; the other group received standard rodent food. The rat brains were assessed using immunohistochemical markers against demyelination, microglial activation, apoptosis, neurons, neurofilament, and reactive astrocytes. To evaluate the effect of VD on oxidative stress and the antioxidant capacity, we used two different oxidized lipid markers (anti- Cu++ and HOCl oxidized LDL antibodies) along with colorimetric methods for protective polyphenols (PP) and total antioxidative capacity (TAC). NfL serum levels of VD+ and VD- animals were analyzed by fourth generation single-molecule array (SIMOA) analysis. We found significant differences between the VD+ and VD- animals both in histopathology as well as in all serum markers. Myelin loss and microglial activation is lower in VD+ animals and the number of apoptotic cells is significantly reduced with a higher neuronal survival. VD+ animals show significantly lower NfL serum levels, a higher TAC, and more PP. Additionally, there is a significant reduction of oxidized lipid markers in animals under VD supplementation. Our data thus show a positive effect of VD on cellular features of cortical pathology in our animal model, presumably due to protection against reactive oxygen species. In this study, VD enhanced remyelination and prevented neuroaxonal and oxidative damage, such as demyelination and neurodegeneration. However, more studies on VD dose relations are required to establish an optimal response while avoiding overdosing.
- Find related publications in this database (using NLM MeSH Indexing)
- Male - administration & dosage
- Rats - administration & dosage
- Animals - administration & dosage
- Vitamin D - administration & dosage
- Antioxidants - pharmacology
- Multiple Sclerosis - drug therapy
- Vitamins - pharmacology, therapeutic use
- Multiple Sclerosis, Chronic Progressive - drug therapy
- Models, Animal - administration & dosage
- Find related publications in this database (Keywords)
- vitamin D
- progressive multiple sclerosis
- animal model
- neuroprotection